Reuters logo
2 months ago
BRIEF-U.S. FDA says approves first generic versions of Strattera
May 30, 2017 / 8:51 PM / 2 months ago

BRIEF-U.S. FDA says approves first generic versions of Strattera

1 Min Read

May 30 (Reuters) - Glenmark Pharmaceuticals Ltd

* U.S. Food and Drug Administration says approved first generic versions of Strattera for attention-deficit/hyperactivity disorder in pediatric, adult patients‍​

* U.S. FDA says Apotex, Teva Pharmaceuticals USA, Aurobindo Pharma, Glenmark Pharmaceuticals gained approval to market Atomoxetine in multiple strengths Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below